Latest

psychosis

·August 17, 2020·4 min read

Targeted Treatment for Depression Could Benefit Patients With Psychosis

Depression treatments, including antidepressants, may be effective first-line treatments for psychosis if used in combination with established interventions for the condition.

Featured Neurology Psychology

·July 29, 2020·1 min read

Pimavanserin Reduced Symptoms of Dementia-Related Psychosis in Phase 3 Trial

Pimavanserin substantially reduces symptoms of psychosis and relapse risk for people living with dementia.

Featured Neurology Open Neuroscience Articles

·July 8, 2020·5 min read

Delirium, Rare Brain Inflammation and Stroke Linked to Covid-19

Coronavirus infection can lead to an array of neurological complications, including delirium, stroke, and a rare, often fatal neuroinflammatory condition called ADEM. The neurological complications did not always correlate with the severity of respiratory symptoms. In some patients, brain inflammation was likely caused by an immune response to COVID-19, suggesting the neurological damage may be a result of immune system activation rather than the virus itself.

Auditory Neuroscience Featured Neuroscience Open Neuroscience Articles Psychology

·July 1, 2020·4 min read

Auditory hallucinations rooted in aberrant brain connectivity

Auditory hallucinations, a common feature of psychosis and schizophrenia, may be the result of increased connectivity between sensory and language processing areas in the brain.

Featured Psychology

·June 18, 2020·3 min read

Suicide rate for people with schizophrenia spectrum disorders 170 times higher

Suicide rates for those with schizophrenia spectrum disorders (SSD) are 170 times higher than the general population. Suicide risk is predicted by key factors including age, evidence of mood disorders and hospitalization. An increased risk of suicidal behavior in those with SSD occurrs within the first five years following diagnosis.

Featured Neuroscience Open Neuroscience Articles Psychology

·June 9, 2020·3 min read

Antioxidants in brain linked to improved psychosis treatment

Patients with psychosis who have higher levels of an antioxidant called glutathione responded more quickly to medications and had improved outcomes. Researchers estimate a 10% increase in antioxidants could lead to reduced time spent in hospital for those with psychosis.

Featured Neuroscience Psychology

·June 5, 2020·3 min read

NMDA receptors may link psychosis and sleep deficits

NMDA receptor hypofunction is involved in the reduction of sleep spindles and delta oscillations, which appear in the brain during deep natural sleep. Findings confirm the role NMDA receptors play in sleep disorders that accompany psychotic states.

Featured Neuroscience Psychology

·June 1, 2020·7 min read

Out-of-sync brain waves may underlie learning deficit linked to schizophrenia

Study reveals specific brain wave patterns that underlie the ability to remove irrelevant learned associations to make way for new, updated information. The research shows a particular behavior can be dependent on the synchronization of high-frequency brain waves in different parts of the brain.

This shows a man looking out of a window

Featured Neuroscience Open Neuroscience Articles Psychology

·May 13, 2020·2 min read

Small but significant number of people will develop coronavirus-related psychosis

The stress of the COVID-19 pandemic may lead to an increased risk of developing psychosis for some people. Additionally, contracting the coronavirus infection may lead to some people developing symptoms of psychosis.

Featured Neuroscience Psychology

·March 29, 2020·5 min read

Thirty risk factors found during and after pregnancy for children developing psychosis

Over 30 prenatal and postnatal environmental risk factors have been identified for the development of psychosis in offspring. The factors have been split into four categories, including parental and familial, pregnancy, labor and delivery, and fetal growth and development. Significant protective factors are lower maternal age, first-time mothers, and babies with higher birth weights.

Featured Neuroscience Open Neuroscience Articles Psychology

·March 20, 2020·6 min read

Single dose of THC may induce short-lived psychiatric symptoms

Analyzing the results of 15 different studies involving over 300 subjects, researchers discovered a single dose of THC could induce psychiatric symptoms in people with no history of psychosis.